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Abstract
Cardiovascular diseases are among the leading causes of disability and death. One of the forms of treatment for them is the 
percutaneous coronary intervention (PCI). After a diagnosis or cardiac procedure, patients have psychological symptoms that 
often go unnoticed and interfere with their health condition. The aim of this article was to evaluate the intensity of anxiety 
and depression symptoms in adult and elderly patients hospitalized after PCI. The design of the study was cross-sectional, 
analytical, correlational and comparative. Participants were 266 patients who had undergone PCI. Their average age was 64.5 
years (SD =8.9 years) and most of them were men (68%) with a diagnosis of acute myocardial infarction (AMI) (64.3%). The 
research instruments used were the Beck Anxiety Inventory (BAI) and the Beck Depression Inventory - Second Edition (BDI-
II). Data collection was performed during the patients’ hospitalization and statistical analysis was carried out by means of the 
Chi-SquareTest, the Kolmogorov –Smirnov Test and ANOVA. The level of significance used was p ≤ .05. Results showed that 
the majority of patients presented severe symptoms of anxiety (29.7%) and minimum intensity depressive symptoms (51.9%). 
The study highlights the importance of assessing and treating psychological symptoms after PCI as these interfere with the 
patient’s adherence to treatment and with their quality of life. 
Key words: Anxiety, depression, percutaneous coronary intervention, hospitalization. 
Síntomas de ansiedad y depresión en adultos y ancianos en  
la post-intervención coronaria percutánea
Resumen
Las enfermedades cardiovasculares están entre las principales causas de incapacidad y mortalidad en el mundo, pero existe 
un modo de tratamiento para estas denominado intervención coronaria percutánea (ICP). Después de un diagnóstico o 
procedimiento cardiaco, los pacientes presentan síntomas psicológicos que a menudo pasan desapercibidos e interfieren con 
su condición de salud. El objetivo del presente artículo fue evaluar la intensidad de los síntomas de ansiedad y depresión en 
pacientes adultos y adultos mayores hospitalizados después de una ICP. Se utilizó un diseño transversal, analítico, correlacional 
y comparativo. En total, participaron 266 pacientes a quienes se les había realizado ICP, estos tenían un promedio de edad de 
64.5 años (DE = 8.9), 68 % eran hombres y 64.3 % presentaban diagnóstico de infarto agudo de miocardio (IAM). Se utilizó 
el Inventario de Ansiedad de Beck (BAI) y el Inventario de Depresión de Beck - Segunda Edición (BDI-II) como instrumentos 
de investigación, y la recolección de datos se realizó durante la hospitalización del paciente. El análisis de datos se llevó a 
cabo por medio de las pruebas Chi-Cuadrado, Kolmogorov-Smirnov y ANOVA, con un nivel de significancia de p ≤ .05. Los 
resultados muestran que la mayoría de los pacientes presentó síntomas de ansiedad graves (29.7 %) y síntomas depresivos de 
intensidad mínima (51.9 %). Estos resultados destacan la importancia de evaluar y tratar los síntomas psicológicos post ICP, 
debido a que estos interfieren en la adhesión al tratamiento y en la calidad de vida del paciente.
Palabras clave: ansiedad, depresión, intervención coronaria percutánea, hospitalización.
Referencia: Della Méa, C.P., Bettinelli, L.A. & Pas-
qualotti, A. (2018). Anxiety and depression symptoms 
in adults and elderly in post-percutaneous coronary 
intervention. Acta colombiana de Psicología, 21(2), 
236-246. doi: http://www.dx.doi.org/10.14718/
ACP.2018.21.2.11
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Sintomas de ansiedade e depressão em adultos e idosos  
na pós-intervenção coronária percutânea
Resumo
As doenças cardiovasculares estão entre as principais causas de incapacidade e mortalidade no mundo. Um dos tratamentos 
indicados é a intervenção coronária percutânea (ICP). Após um diagnóstico ou procedimento cardíaco, os pacientes apresentam 
sintomas psicológicos que costumam passar despercebidos e interferem na sua condição de saúde. O objetivo do presente 
artigo foi avaliar a intensidade dos sintomas de ansiedade e depressão em pacientes adultos e idosos hospitalizados depois de 
uma ICP. Trata-se de um estudo transversal, analítico, correlacional e comparativo. Participaram 266 pacientes que realizaram 
ICP. A média de idade dos pacientes foi de 64.5 anos (DP = 8.9), 68% eram homens e 64.3% apresentavam diagnóstico de 
infarto agudo do miocárdio (IAM). Utilizou-se o Inventário de Ansiedade de Beck (BAI) e o Inventário de Depressão de 
Beck - Segunda Edição (BDI-II) como instrumentos de pesquisa e a coleta de dados foi realizada durante a hospitalização 
do paciente. A análise de dados foi realizada por meio dos testes Qui-Quadrado, Kolmogorov-Smirnov e ANOVA, com um 
nível de significância de p ≤ .05. Os resultados mostram que a maioria dos pacientes apresentou sintomas de ansiedade graves 
(29.7%) e sintomas depressivos de intensidade mínima (51.9%). Esses resultados destacam a importância de avaliar e tratar os 
sintomas psicológicos pós-ICP, uma vez que interferem na adesão ao tratamento e na qualidade de vida do paciente.
Palavras-chave: ansiedade, depressão, hospitalização, intervenção coronária percutânea.
INTRODUCTION
Coronary artery disease (CAD) is characterized by a de-
posit of lipids in cells lining the wall of an artery, obstructing 
the blood flow to the heart (Bonow, Mann, Zipes, & Libby, 
2013). The clinical manifestations of CAD involve myocar-
dial ischemia, acute myocardial infarction (AMI), congestive 
heart failure and sudden death (Magalhães et al., 2015). The 
risk factors for CAD are family history, obesity, sedentarism, 
diabetes, hypertension, smoking, and psychosocial factors, 
such as symptoms of anxiety and depression (Bonow et al., 
2013; Timerman, Ferreira, & Bertolami, 2012).
One of the treatments for CAD is percutaneous coronary 
intervention (PCI), which includes the balloon angioplasty, 
the implantation of the intracoronary stents and other in-
terventions with the use of catheters. An inflated balloon is 
used inside the occluded coronary artery, which compresses 
the atherosclerotic plaque against the vessel wall, thus 
allowing clearance and use of stents, consisting of small 
prostheses with the shape of a tube, expandable, to reduce 
the blockage or narrowing of the artery. The coronary stents 
are divided into two categories: non-pharmacological and 
pharmacological (Levine et al., 2011; Mattos et al., 2008). 
The choice of treatment will depend on the stage and the 
severity manifested by the pathology (Centemero, 2014).
The symptoms of anxiety are related to the development 
of cardiac events in the general population. A meta-analysis 
study concluded that anxiety is considered a risk factor 
for cardiac patients, being associated with adverse cardiac 
events, new cardiac events and causes of mortality (Roest, 
Martens, Jonge, & Denollet, 2010). Depressive symptoms 
are also related to certain hearth diseases, and may be 
considered as a cause, risk factor or consequence of them 
(May et al., 2009; Sardinha, Araujo, Silva, & Nardi, 2011).
Even though the psychological symptoms could be 
frequent and have a serious impact on patients' lives, often 
they pass unnoticed (Ceccarini, Manzoni, & Castelnuovo, 
2014; Huffman, Celano, & Januzzi, 2010). In addition to 
presenting higher rates of morbidity and mortality in the 
long term, if these symptoms are not treated, both quality 
of life and the outcome of the disease can be impaired 
(Jeenger, Wadhwa, & Mathur, 2014).
The objective of the present study was to describe the 
socio-demographic profile, cardiac diagnosis, risk factors 
and aspects related to the mental health of adult and elderly 
patients hospitalized after PCI and to analyze the relation-
ship of these parameters with the intensity of anxious and 
depressive symptoms in these patients.
METHOD
Delineation
This is a cross-sectional, analytical study, of correlational 
and comparative nature (Volpato, 2017). 
Participants
266 adult and elderly patients who had undergone PCI par-
ticipated in the study. All patients, aged 50 years old or more, 
who did not present dementia diagnosis, were literate, had been 
subjected to PCI and were hospitalized, were included. Patients 
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who presented a dementia diagnosis or visual impairment that 
hindered filling out the instruments, and patients who did not 
know how to read and write were excluded. The confirmation 
of extreme dementia diagnosis occurred in advance, through 
the consultation of medical records.
The sample was stratified by sex (male and female) and age 
(50 to 59 years old; 60 years old or more). It was selected out 
of a population of 793 patients, according to data from 2014 
described in the DATASUS (Brazil, 2015), with a sampling 
error of 5% and a confidence interval of 95%. The minimum 
sample size determined was 266 patients who were subjected 
to PCI and distributed as follows: a) 183 men (46 of them 
aged between 50 and 59 years old and 137 aged 60 years old 
or more) and 83 women (16 of them aged between 50 and 
59 years old and 67 aged 60 years old or more).
The average age was 64.5 years old (SD = 8.9 years old). 
Most patients were males (68%), had elementary school edu-
cation (80.1%), were married (79.7%), lived with someone 
else (89.1%) and had children (94.4%). The cardiac diagnosis 
for the majority of patients was AMI (64.3%); most of them 
also had a family history of heart disease (62.8%) and had 
undergone angioplasty with stent placement (95.1%), by 
the National Health System (NHS) (97.7%). The average 
time of diagnosis was of 1680.8 days (SD = 2429.3 days).
Instruments
A questionnaire was constructed for this study with 
the objective of collecting information related to socio-
demographic data, cardiac diagnosis, risk factors and data 
concerning the mental health of patients hospitalized after PCI.
 The Beck Anxiety Inventory (BAI) consists of a scale 
of 21 symptoms, whose objective is to assess the intensity 
of anxiety symptoms. Cunha validated the instrument for 
the Brazilian population in 2001. The scale measures the 
following symptoms: numbness or tingling; heat sensation; 
tremors in the legs; inability to relax; fear that the worst 
might happen; dizziness; palpitations or heart acceleration; 
imbalance; fearfulness; nervousness; suffocation sensation, 
shaky hands; tremors; fear of losing control; fear of dy-
ing; shortness of breath,; dread, indigestion or discomfort 
in the abdomen; fainting sensation; burning face; sweat 
(not because of heat). The assessment is performed with 
a 4 points Likert scale (0-3), where the maximum score is 
63 points. As a result, the minimum level of anxiety cor-
responds to a score ranging from 0-10; mild level, from 
11-19; moderate, from 20-30 and severe, from 31-63. In 
studies for validation with the Brazilian population, the 
instrument presented a Cronbach's alpha precision index 
ranging from 0.83 to 0.92 for non-clinical samples and from 
.75 to .92 for a medical-clinical sample (Cunha, 2001).
The Beck Depression Inventory - Second Edition 
(BDI-II) is a scale with 21 items, including symptoms and 
behaviors related to depression. It was validated for Brazil 
by Gorenstein, Pang, Argimon and Werlang in 2011. The 
assessed items on the scale are: sadness, pessimism, past 
failure, loss of pleasure, sense of guilt, sense of punishment, 
self -esteem, self-criticism, suicidal thoughts or desires, 
crying, agitation, loss of interest, indecision, devaluation, 
lack of energy, changes in the sleep pattern, irritability, 
changes in appetite, difficulty in concentrating, tiredness 
or fatigue, loss of interest in sex. The scale items allow 
the assessment of increasing severity of depression. The 
assessment is carried out with a 4 points (0-3) Likert scale, 
where the maximum score is 63 points, and items 16 and 
18 have seven response options to assess the increase and 
decrease of behavior. The total score indicates the severity of 
depression in terms of minimum (a score from 0 to13), mild 
(14-19), moderate (20-28) and severe (29-63) (Gorenstein, 
Pang, Argimon, & Werlang, 2011).In a validation study in 
Brazil, the BDI-II presented a Cronbach's alpha precision 
index of .93 in a non-clinical sample (Gomes-Oliveira, 
Gorenstein, Lotufo Neto, Andrade, & Wang, 2012). 
Procedure
The data collection took place in the hemodynamic sector 
of a hospital located in southern Brazil, within the period of 
May to October 2016. In the shift after they have performed 
the PCI, the researcher went to the location and presented the 
research objectives to the patients whose profile correspon-
ded with the study’s inclusion criteria, and invited them to 
participate in it. All the patients signed the Informed Consent 
Form, according to resolution 466/12 of the National Health 
Council. In the free and clarified consent form, it was stated 
that the study did not involve any risk to the physical health 
of patients but that filling out the instruments could generate 
some emotional discomfort. If this occurred, the application 
of the instrument would be suspended by the researcher.
The questionnaire was completed by the researcher, and 
the BAI and the BDI-II, by the patients, in an estimated 
period of approximately 30 minutes. The Research Ethics 
Committee of the University of Passo Fundo/RS, report 
1.389.673, approved the research. 
Data analysis
To analyze the collected data, the Chi-Square Test, 
Kolmogorov-Smirnov Test and ANOVA were used. The 
level of significance was p ≤ .05.
The Chi-Square Test was applied to analyze the com-
parison of sociodemographic data, cardiac diagnosis, risk 
factors and data related to the intensity of the symptoms of 
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anxiety and depression. The Kolmogorov-Smirnov Test was 
used to analyze normality. With respect to the ANOVA’s 
analysis, it was applied to compare the average age at the 
time of cardiac diagnosis, considering the amount of times 
per week that the patient performed physical activity, the 
amount of cigarettes that he smoked per week, the time 
elapsed since he stopped smoking, the amount of alcohol 
consumption, the time elapsed since the previous diagnosis 
of anxiety and depressive disorder, as well as the dosage of 
psychiatric medication prescribed according to the intensity 
of the symptoms of anxiety and depression. 
RESULTS
The following results will be presented regarding the risk 
factors, aspects related to mental health and the intensity of 
anxiety and depression symptoms of hospitalized patients 
after percutaneous coronary intervention. Also, the relation-
ship between the intensity of anxiety and depression with 
socio-demographic data, risk factors and aspects related to 
the mental health of these patients is shown.
In terms of risk factors, the majority was composed by 
hypertensive subjects (83.5%) that presented dyslipidemia 
(51.5%), but who did not have diabetes (61.7%) or obe-
sity (81.6%). The majority (69.9%) performed physical 
activity, with an average of 4.08 (SD = 2.16) times per 
week. Regarding tobacco consumption, the majority were 
ex-smokers (44.7%); the average of smoked cigarettes per 
week in smokers was 135.4 (SD = 117.9) and the average 
of ex-smokers in relation to the time elapsed since the date 
when they stopped smoking was 54.299.6 (SD = 4.786.5) 
months. Concerning alcohol consumption, the majority of 
patients did not use it (80.8%), and among those who did, 
most of them consumed beer (12%), being the average 
ingestion 1.3L (SD = 1.3) per week.
 The assessment of prior diagnostic of anxiety and depres-
sive disorder was done by self-report. The majority did not 
provide diagnosis of anxiety disorder before the PCI (95.1%), 
and none of them had had a previous diagnosis of depressive 
disorder (81.2%). Among those who had a previous diagno-
sis of anxiety disorder, the average time of diagnosis was 
128.9 months (SD = 139.8) and of depressive disorder was 
327.3 months (SD = 1.449.1). The majority did not receive 
psychological treatment (99.6%), and did not take psychiatric 
medication (78.9%). The category of anxiolytics appeared more 
frequently in those who used psychotropic drugs (62.5%). 
Regarding the quantitative variables, the Kolmogorov-
Smirnov test showed no rejection, according to Table 1.
Most patients presented symptoms of anxiety at a se-
vere level (29.7%) and depressive symptoms of minimum 
intensity (51.9%), as shown in Table 2.
Table 2
Presence of symptoms of anxiety and depression in post-PCI
Symptoms Level/Intensity N %
Minimum 70 26.3
Anxiety
Mild 59 22.2
Moderate 58 21.8
Severe 79 29.7
Depression
Minimum 138 51.9
Mild 69 25.9
Moderate 34 12.8
Severe 25 9.4
The average age of the patients with symptoms of anxiety 
at a minimum level was 66.61 (SD =9.42), at mild level 
was 65.17 (SD= 8.97), at moderate level was 62.00 (SD= 
8.18) and at severe level was of 63.89 (SD=8.52) years old. 
A significant difference in terms of the average age among 
the minimum and moderate symptoms of anxiety (p =.026) 
was found with the use of ANOVA, as described in Table 3.
Table 1 
Kolmogorov-Smirnov test of a sample
Variables N Normal parameters
Statistical testAverage Standard deviation
Age 266 64.48 8.93 .069
Time elapsed since diagnosis 266 1680.75 2429.26 .245
Times per week that the patient performs physical activity 80 4.08 2.17 .227
Quantity of cigarettes that smokes per week 45 135.36 117.94 .329
Time elapsed since quitting smoking 266 54259.56 49786.48 .362
Quantity of alcohol consumption 51 1306.27 1384.00 .202
Time elapsed since diagnosis of anxiety 13 128.85 139.81 .226
Time elapsed since diagnosis of depression 49 327.69 1449.9 .430
Medication dosage 56 18.62 44.72 .340
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Table 3
Relationship between level of anxiety symptoms and ave-
rage age
Level of anxiety  
symptoms N
Age
pAverage
Standard 
deviation
Minimum 70 66.61 9.42
.026Mild 59 65.17 8.97
Moderate 58 62.00 8.18
Severe 79 63.89 8.63
Note: ANOVA (F = 3.131); Tukey Test. The averages are 
shown for the groups in homogeneous subsets. The sample 
size was used to define the harmonic average (Average age 
= 65.43), since the group sizes were unequal.
 The relationship between the socio-demographic data 
and the level of anxiety symptoms were evaluated through 
the Chi-Square Test. There was a significant difference 
for sex (p < .001), i.e., women showed a level of severe 
anxiety. No significant difference was found for schooling 
(p = .685), marital status (p = .094), living with somebody 
(p = .217), and having children (p = .111). There was no 
significant difference for the cardiac diagnosis (p = .611) 
and the procedure performed (p = .946). 
In the calculation that related risk factors with intensity 
levels of anxiety symptoms, by means of the Chi-Square 
Test, there was a significant difference with respect to family 
history (p = .011), as shown in Table 4.
Referring to aspects related to mental health, the Chi-
Square Test showed a significant difference in the previous 
diagnosis of depressive disorder (p = .011). No significant 
difference was found for prior diagnosis of anxiety disorder 
(p = .550), use of psychotropic drugs (p = .663) and type 
of medication (p = .738). 
Table 4
Level of anxiety symptoms and risk factors present in hospitalized patients in post-PCI
Variables Categories Anxiety (BAI) Total p
Minimum Mild Moderate Severe
Family History
Yes
36
(51.4)
32
(54.2)
41
(70.7)
58
(73.4)
167
(62.8) .011
No
34
(48.6)
27
(45.8)
17
(29.3)
21
(26.6)
99
(37.2)
Diabetes
Yes
23
(32.9)
20
(33.9)
25
(43.1)
34
(43)
102
(38.3) .444
No
47
(67.1)
39
(66.1)
33
(56.9)
45
(57)
164
(61.7)
Hypertension
Yes 
60
(85.7)
49
(83.1)
47
(81)
66
(83.5)
222
(83.5) .916
No
10
(14.3)
10
(16.9)
11
(19)
13
(16.5)
44
(16.5) 
Obesity
Yes
10
(14.3)
11
(18.6)
8
(13.8)
20
(25.3)
49
(18.4) .248
No 
60
(85.7)
48
(81.4)
50
(86.2)
59
(74.7)
217
(81.6)
Dyslipidemia
Yes 
29
(41.4)
34
(57.6) 
31
(53.4)
43
(54.4)
137
(51.5) .252
No
41
(58.6)
25
(42.4)
27
(46.6)
36
(45.6)
129
(48.5)
Physical Activity
Yes
46
(65.7)
44
(74.6)
40
(69)
56
(70.9)
186
(69.9) .739
No
24
(34.3)
15
(25.4)
18
(31)
23
(29.1)
80
(30.1)
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The ANOVA Test did not show a significant differen-
ce regarding time elapsed since diagnosis (p = .888), the 
amount of times per week that the patient performs phy-
sical activity (p = .899), the number of cigarettes that he 
smokes per week (p = .165), the time elapsed since quitting 
tobacco (p = .378), the amount of alcohol consumption 
(p = .162), the time elapsed since the diagnosis of anxiety 
disorder (p = .685), the time elapsed since the diagnosis 
of depressive disorder (p = .752) and about the medication 
dosage (p = .624).
Regarding the intensity of depressive symptoms and 
average age, the ANOVA Test showed that there was no 
significant difference (p = .070), as shown in Table 5. 
Table 5
Relationship between intensity of depressive symptoms 
and average age
Intensity of 
depressive 
symptoms N
Age
pAverage
Standard 
deviation
Minimum 138 64.09 8.58
.070
Mild 69 66.23 9.20
Moderate 34 65.09 9.68
Severe 25 60.92 8.27
Note. ANOVA (F = 3.131); Tukey Test. The averages are 
shown for the groups in homogeneous subsets. The sample 
size was used to define the harmonic average (Average 
age = 43.88), since the sizes of the groups were unequal.
In respect to gender, women showed more 
depressive symptoms of severe intensity (p < .001). 
There was no significant difference in schooling (p = 
.369), marital status (p = .234), living with somebody 
(p = .136) and having children (p = .908). 
In the calculation that related risk factors with intensity 
of depressive symptoms, using the Chi-Square Test, no 
considerable differences were found, as shown in Table 6.
Regarding mental health issues, the Chi-Squared Test 
showed no significant difference for the previous diagnosis 
of anxiety disorder (p = .081). With respect to the previous 
diagnosis of depressive disorder, there was a significant 
difference (p = .001). There was no difference for use of 
psychiatric medication (p = .086) and type of medication 
(p = .367).
The ANOVA Test did not show a significant difference 
in terms of the time elapsed since the cardiac diagnosis (p 
= .430), or about how often the patient performed physical 
activity (p = .644), the amount of cigarettes he smoked per 
week (p = .611), the time elapsed since quitting tobacco, (p 
= .401), the amount of alcohol consumption (p = .950), time 
elapsed since the diagnosis of anxiety disorder (p =.870), 
time elapsed since the diagnosis of depressive disorder 
(p = .166) and the medication dosage (p = .504).
DISCUSSION
The patients´ demographic profile found in this study 
corroborates the data from other studies. A similar study was 
carried out in a U.S.A. hospital, where 70% of the patients 
were men, with an average age of 62 years old (Watkins et 
al., 2013). Another study in the Netherlands also found that 
76.9% were men, with an average age of 63.3 years old 
(Damen et al., 2013). Data relating to marital status agree 
with the results of a study conducted in Brazil, where most 
participants of the sample were married or living in a stable 
union (Furuya et al., 2013). In terms of schooling, a survey 
conducted in Brazil showed that 44% of the patients had 
Variables Categories Anxiety (BAI) Total p
Minimum Mild Moderate Severe
Smoking
Smoker
9
(12.9)
10
(16.9)
8
(13.8)
18
(22.8)
45
(16.9)
.617Ex-smoker
36
(51.4)
27
(45.8)
26
(44.8)
30
(38)
119
(44.7)
Non-smoker
25
(35.7)
22
(37.3)
24
(41.4)
31
(39.2)
102
(38.3)
Use of alcohol 
Yes
15
(21.4)
13
(22)
11
(19)
12
(15.2)
51
(19.2) .717
No
55
(78.6)
46
(78)
47
(81)
67
(84.8)
215
(80.8)
Note. Values in brackets represent the percentages; the Chi-Squared Test; significant value for p ≤ .05.
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PCI reduces mortality and ischemic events and improves 
quality of life (Blankenship et al., 2013).
As far as risk factors are concerned, the findings coincide 
with the conclusions of a research carried out with patients 
after PCI in Brazil, of which 100% were hypertensive and 
93.8% had dyslipidemia (Richter et al., 2015). In a study 
conducted in Iran, 36.8% were hypertensive and 21.4% 
were diabetic (Hosseini, Ghaemian, Mehdizadeh, & Ashraf, 
2014). In a research that aimed to determine the preva-
lence of risk factors for DAC in cities of southern Brazil, 
completed elementary school (Schmidt et al., 2011). It is 
estimated that NHS is responsible for 80% of PCIs carried 
out in Brazil (Piegas & Haddad, 2011).
Regarding the procedure, the data corroborate a study 
conducted in India, in which 90% of the patients did the 
angioplasty with stent placement (Chaudhury & Srivastava, 
2013), and in another study, 100% also implanted stent 
(Schmidt et al., 2011). In respect of the diagnosis, in a study 
carried out in Portugal, the majority had a diagnosis of AMI 
(58.8%) (Pacheco & Santos, 2015), and it was found that 
Table 6
Intensity of depressive symptoms in terms of risk factors for hospitalized patients in post-PCI
Variables Categories Depression (BDI-II) Total p
Minimum Mild Moderate Severe
Family History
Yes
83
(60.1)
44
(63.8)
21
(61.8)
19
(76)
167
(62.8) .508
No
55
(39.9)
25
(36.2)
13
(38.2)
6
(24)
99
(37.2)
Diabetes
Yes
56
(40.6)
22
(31.9)
14
(41.2)
10
(40)
102
(38.3) .647
No
82
(59.4)
47
(68.1)
20
(58.8)
15
(60)
164
(61.7)
Hypertension
Yes 
118
(85.5)
54
(78.3)
27
(79.4)
23
(92)
222
(83.5) .321
No
20
(14.5)
15
(21.7)
7
(20.6)
2
(8)
44
(16.5) 
Obesity
Yes
23
(16.7)
12
(17.4)
10
(29.4)
4
(16)
49
(18.4) .367
No 
115
(83.3)
57
(82.6)
24
(70.6)
21
(84)
217
(81.6)
Dyslipidemia
Yes 
65 (47.1)
39
(56.5) 
18
(52.9)
15
(60)
137
(51.5) .472
No
73
(52.9)
30
(43.5)
16
(47.1)
10
(40)
129
(48.5)
Physical Activity
Yes
101
(73.2)
45
(65.2)
21
(61.8)
19
(76)
186
(69.9) .401
No
37
(26.8)
24
(34.8)
13
(38.2)
6
(24)
80
(30.1)
Smoking
Smoker
21
(15.2)
11
(15.9)
7
(20.6)
6
(24)
45
(16.9)
.797Ex- smoker 
63
(45.7)
34
(49.3)
14
(41.2)
8
(32)
119
(44.7)
Non-smoker
54
(39.1)
24
(34.8)
13
(38.2)
11
(44)
102
(38.3)
Use of alcohol 
Yes
32
(23.2)
13
(18.8)
4
(11.8)
2
(8)
51
(19.2) .199
No
106
(76.8)
56
(81.2)
30
(88.2)
23
(92)
215
(80.8)
Note: Values in brackets represent the percentages; the Chi-Squared Test; significant value for a p ≤ .05.
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dyslipidemia was found in 43% and hypertension in 40% 
of patients (Gus et al., 2015). In this study, the majority of 
patients performed physical activity; they were ex-smokers 
and did not use alcohol. In other findings, the majority did 
not smoke cigarettes (47.5%) (Chaudhury & Srivastava, 
2013) and also did not consume alcoholic beverages (55.6%) 
(Pacheco & Santos, 2015).
In this research, most patients had no previous diagnosis 
of anxiety disorder and depressive disorder, they didn´t use 
psychiatric medication and did not received psychological 
treatment. The data are in agreement with another study, 
which showed that 76% of the patients had never received 
psychiatric treatment, 31% reported making use of psycho-
tropic drugs and 12% had a previous diagnosis of depressive 
disorder (Schmidt et al., 2011). The literature highlights that 
the psychological treatment for cardiac patients reduces 
symptoms of anxiety and depression, pain and, therefore, 
improves the quality of life (Chaudhury & Srivastava, 2013; 
Ski, Jelinek, Jackson, Murphy, & Thompson, 2016). When 
the patient presents psychological symptoms that primarily 
compromise adherence to clinical treatment, a referral to 
psychotherapy is necessary (Jeenger et al., 2014).
In this study, the majority of patients presented symp-
toms of anxiety at a severe level and depression with a 
minimum intensity. The findings confirm the information 
from a research that showed symptoms of anxiety in 29% 
of patients and depression in 25%, using the BAI and the 
Beck Depression Inventory (BDI) (Schmidt et al., 2011). 
Another study in Brazil that used the Hospital Anxiety and 
Depression Scale (HADS) as assessment instrument, found 
that 32.5% of the patients presented symptoms of anxiety 
and 17.5% of depression (Carvalho et al., 2016). In another 
research using the same instrument, approximately 20% of 
the sample presented symptoms of anxiety and depressive 
disorder clinically significant (Watkins et al., 2013).
A study – which had as instruments the BDI-II and The 
Self-Rating Anxiety Scale (SAS) – and aimed to verify 
the prevalence of depression and anxiety in patients in 
the Czech Republic, identified depressive symptoms in 
21.5% of the patients and anxiety symptoms in 8.9% of 
them after 24 hours of PCI (Kala et al., 2016). The specia-
lized literature points out that patients affected by an AMI 
have symptoms of anxiety and depression after diagnosis, 
resulting in a lower probability of resuming their work 
activities, less tolerance to the practice of physical activi-
ty, less adherence to medical treatment, cognitive decline 
and lower quality of life (Huffman et al., 2010; Mattos 
et al., 2008; O'Neil, Sanderson, & Oldenburg, 2010). In 
addition, these symptoms are associated with higher rates 
of complications, the possibilities of reinfarction and the 
risk of death (Mastrogiannis et al., 2012; Norlund, Olsson, 
Burell, Wallin, & Held, 2015).
This study showed that patients with lower age showed 
a higher level of anxiety symptoms. In another study, there 
was a correlation between anxiety scores and younger age 
(p < .001) (Watkins et al., 2013).These findings corrobo-
rate a cohort study conducted in Asia, where patients with 
ages between 45 and 64 years old presented a higher risk 
of anxiety (Feng et al., 2016). Elderly patients who have 
already thought of their own death may experience fewer 
symptoms of anxiety (Zhao, Luo, Wang, & Su, 2008).
The study showed that there was a relationship between 
anxiety symptoms and a family history of heart disease. 
The literature points to heredity as a risk factor for CAD 
(Bonow et al., 2013) and a research confirmed that 50% 
of the patients had a history of heart disease in the family 
(Gus et al., 2015). In a study that sought to characterize the 
profile of patients with symptoms of anxiety in a hospital 
in Brazil, it was identified that 41.3% of the sample had a 
family history of VCDs (Bochi, Ribeiro, & Paes, 2014). 
Similarly, in another finding, 67% of the patients had a 
family history of this condition (Lucena et al., 2016). 
An association was found between anxiety symptoms 
and previous diagnosis of depressive disorder (p = .011); 
in other words, patients who had a previous diagnosis of 
depressive disorder presented symptoms of anxiety at a 
severe level. Patients diagnosed with depressive disorder 
have a negative vision of themselves, characterized by 
pessimistic and hopeless thoughts (Beck, 2013). The pa-
tients’ beliefs about the disease influence the management 
of their pathology, revealing ideas, concepts and attitudes 
about the care and own health (Bonetti, Silva, & Trentini, 
2013; Gama, Musi, Pires, & Guimarães, 2012). 
In terms of the presence of anxiety symptoms, there was 
a relationship with sex; in other words, women showed a 
higher prevalence of these symptoms (p < .001) at a seve-
re level. This supports the results of other studies, which 
have found a correlation between symptoms of anxiety 
and female sex (p = .032) (Watkins et al., 2013), and with 
patients hospitalized in Brazil, where anxiety symptoms 
were also associated with females (p = .002) (Carvalho et 
al., 2016). Furthermore, patients who used medication for 
depression or anxiety had higher scores in the assessment 
of anxiety (Trotter, Gallagher & Donoghue, 2011). 
In the same way, other studies also revealed that wo-
men experienced more depressive symptoms than men 
24 hours after the PCI (p < .001) (Kala et al., 2016) and 
depressive symptoms were associated with female sex (p 
= .022) (Carvalho et al., 2016). Another study found that 
women had more depressive symptoms (43.7%) when 
compared to men (14.8%) and the difference between the 
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groups was significant (p < .001) (Furuya et al., 2013). 
Depressive symptoms in women are related to biological 
matters, psychosocial aspects (Dessotte et al., 2015) and 
cultural issues, since women tend to express their feelings 
more openly, have more freedom to cry and seek expert 
help from health professionals more frequently than men 
(Emslie, Ridge, Ziebland, & Hunt, 2007; Fernandes, 
Nascimento, & Costa, 2010).
Another significant factor has to do with the previous 
diagnosis of depressive disorder. In other words, patients 
who already had this diagnosis had the highest score of 
depressive symptoms of severe intensity (p < .001). It is 
estimated that individuals with a diagnosis of this patho-
logy have twice the risk of developing CAD (Khawaja, 
Westermeyer, Gajwani, & Feinstein, 2009). If the patient 
already had a history of depressive symptoms before the 
cardiac diagnosis or if there are cases of depression in the 
family, there will be a higher probability of presenting those 
symptoms (Blay, Andreoli, Fillenbaum, & Gasta, 2007).
Based on this study, it can be concluded that symptoms 
of anxiety at a severe level and depressive symptoms of 
minimum intensity were found in adult and elderly patients 
who underwent PCI. It was found that younger patients 
had higher scores of symptoms of anxiety and depression. 
There was an association between symptoms of anxiety 
with the female sex, with a family history of heart disease 
and diagnosed with major depressive disorder before PCI. 
Depressive symptoms were also related to the female 
gender, as well as to the previous diagnosis of depressive 
disorder. Therefore, the importance of assessing psycholo-
gical symptoms after the intervention, as well as the need 
for follow-up by a psychology professional in this context 
is evident. 
One of the limitations of this research is the fact that 
the sample was not compared with individuals who had 
not been submitted to cardiac intervention. It is suggested 
that new studies are conducted using a longitudinal design 
to monitor these patients post-discharged from hospital. 
Furthermore, psychological intervention studies during 
hospitalization should be carried out, in order to verify 
whether there is a decrease of anxiety symptoms.
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